146 related articles for article (PubMed ID: 32482537)
1. Clinicopathologic study of 6 cases of epithelioid osteoblastoma of the jaws with immunoexpression analysis of FOS and FOSB.
Pereira TDSF; Andrade BAB; Romañach MJ; Pereira NB; Gomes CC; Mariz BALA; Almeida OP; Agostini M; van Heerden WFP; Carlos R; Gomez RS; Fonseca FP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):191-199. PubMed ID: 32482537
[TBL] [Abstract][Full Text] [Related]
2. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.
Lam SW; Cleven AHG; Kroon HM; Briaire-de Bruijn IH; Szuhai K; Bovée JVMG
Virchows Arch; 2020 Mar; 476(3):455-463. PubMed ID: 31768625
[TBL] [Abstract][Full Text] [Related]
3. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
Saba KH; Cornmark L; Hofvander J; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Foijer F; Staaf J; Brosjö O; Sumathi VP; Lam SW; Szuhai K; Bovée JV; Kovac M; Baumhoer D; Styring E; Nord KH
J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935
[TBL] [Abstract][Full Text] [Related]
4. New kids on the block:
Cordier F; Creytens D
J Clin Pathol; 2023 Nov; 76(11):721-726. PubMed ID: 37553246
[No Abstract] [Full Text] [Related]
5. Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
Ameline B; Nathrath M; Nord KH; de Flon FH; Bovée JVMG; Krieg AH; Höller S; Hench J; Baumhoer D
Mod Pathol; 2022 Sep; 35(9):1204-1211. PubMed ID: 35347251
[TBL] [Abstract][Full Text] [Related]
6. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid Multinodular Osteoblastoma of the Mandible: A Case Report and Review of Literature.
Kashikar S; Steinle M; Reich R; Freedman P
Head Neck Pathol; 2016 Jun; 10(2):182-7. PubMed ID: 26507845
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid osteoblastoma. Clinicopathologic and immunohistochemical study of 17 cases.
Suster D; Mackinnon AC; Jarzembowski JA; Carrera G; Suster S; Klein MJ
Hum Pathol; 2022 Jul; 125():68-78. PubMed ID: 35337839
[TBL] [Abstract][Full Text] [Related]
9. Recurrent rearrangements of FOS and FOSB define osteoblastoma.
Fittall MW; Mifsud W; Pillay N; Ye H; Strobl AC; Verfaillie A; Demeulemeester J; Zhang L; Berisha F; Tarabichi M; Young MD; Miranda E; Tarpey PS; Tirabosco R; Amary F; Grigoriadis AE; Stratton MR; Van Loo P; Antonescu CR; Campbell PJ; Flanagan AM; Behjati S
Nat Commun; 2018 Jun; 9(1):2150. PubMed ID: 29858576
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study.
Tsuda Y; Suurmeijer AJH; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2021 Jan; 60(1):17-25. PubMed ID: 33034932
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid osteoblastoma with secondary aneurysmal bone cyst and FOS gene rearrangement.
Snow JT; Edgar MA; Halphen CR; Stanborough RO; Garner HW
Skeletal Radiol; 2022 Mar; 51(3):673-679. PubMed ID: 34448010
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are Pitfalls in Interpretation Including Expression in Other Vascular Lesions.
Tsui KY; Maclean F; Moir D; Cheah A; Bonar F; Tabot J; Gill AJ; Vargas AC
Int J Surg Pathol; 2023 May; 31(3):280-288. PubMed ID: 35635207
[No Abstract] [Full Text] [Related]
13. FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia).
Ortins-Pina A; Llamas-Velasco M; Turpin S; Soares-de-Almeida L; Filipe P; Kutzner H
J Cutan Pathol; 2018 Jun; 45(6):395-402. PubMed ID: 29527734
[TBL] [Abstract][Full Text] [Related]
14. Benign Bone-Forming Tumors.
Amary F; Flanagan AM; O'Donnell P
Surg Pathol Clin; 2021 Dec; 14(4):549-565. PubMed ID: 34742480
[TBL] [Abstract][Full Text] [Related]
15. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
16. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters.
Oliveira CR; Mendonça BB; Camargo OP; Pinto EM; Nascimento SA; Latorre Mdo R; Zerbini MC
Clinics (Sao Paulo); 2007 Apr; 62(2):167-74. PubMed ID: 17505702
[TBL] [Abstract][Full Text] [Related]
17. FOS Rearrangement and Expression in Cementoblastoma.
Lam SW; Cleven AHG; Briaire-de Bruijn IH; Schreuder WH; Kroon HM; Savci-Heijink DC; Suurmeijer AJH; Szuhai K; Bovée JVMG; Baumhoer D
Am J Surg Pathol; 2021 May; 45(5):690-693. PubMed ID: 33653978
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Primary Epithelioid Hemangioma of Bone with
Yuen LC; Baker ML; Sin JM; Linos K; Kerr DA
Int J Surg Pathol; 2023 Aug; 31(5):667-674. PubMed ID: 35946109
[TBL] [Abstract][Full Text] [Related]
19. Epithelioid multinodular osteoblastoma: a clinicopathologic analysis of 26 cases.
Zon Filippi R; Swee RG; Krishnan Unni K
Am J Surg Pathol; 2007 Aug; 31(8):1265-8. PubMed ID: 17667552
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory lobular hemangioma (T-cell-rich angiomatoid polypoid pseudolymphoma)-Assessment of FOS/FOSB and lymphoid markers and comparison with epithelioid hemangioma.
Vargas AC; Maclean FM; Tsu KY; Ma L; Moir D
J Cutan Pathol; 2022 Dec; 49(12):1067-1073. PubMed ID: 36008878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
